BCM
Boone Capital Management Portfolio holdings
AUM
$233M
This Quarter Return
+12.96%
1 Year Return
+15.17%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$386M
AUM Growth
+$386M
(+0.62%)
Cap. Flow
-$41.3M
Cap. Flow
% of AUM
-10.7%
Top 10 Holdings %
Top 10 Hldgs %
75.9%
Holding
21
New
2
Increased
6
Reduced
8
Closed
4
Top Buys
| 1 |
Chemed
CHE
|
$23.7M |
| 2 |
Perrigo
PRGO
|
$11.9M |
| 3 |
IDEAYA Biosciences
IDYA
|
$3.47M |
| 4 |
Orthofix Medical
OFIX
|
$2.42M |
| 5 |
Unum
UNM
|
$2M |
Top Sells
| 1 |
Danaher
DHR
|
$12.5M |
| 2 |
Baxter International
BAX
|
$10.6M |
| 3 |
Charles River Laboratories
CRL
|
$9.98M |
| 4 |
Xenon Pharmaceuticals
XENE
|
$9.77M |
| 5 |
Molina Healthcare
MOH
|
$9.44M |
Sector Composition
| 1 | Healthcare | 80.83% |
| 2 | Financials | 14.86% |
| 3 | Materials | 4.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Unum
UNM
$11.9B
| $57.3M | 14.86% | 964,170 +33,625 | +4% | +$2M |
|
2
Globus Medical
GMED
$8.27B
| $46.6M | 12.09% | 651,710 +14,395 | +2% | +$1.03M |
|
3
Cigna
CI
$80.3B
| $45.7M | 11.85% | 131,926 | – | – |
|
|
4
Molina Healthcare
MOH
$9.8B
| $24.7M | 6.4% | 71,704 -27,390 | -28% | -$9.44M |
|
|
5
Chemed
CHE
$6.67B
| $23.7M | 6.14% | +39,422 | New | +$23.7M |
|
6
Pennant Group
PNTG
$830M
| $22.9M | 5.93% | 641,255 -58,711 | -8% | -$2.1M |
|
7
Mirum Pharmaceuticals
MIRM
$3.71B
| $21.2M | 5.5% | 543,843 +20,164 | +4% | +$786K |
|
|
8
Danaher
DHR
$147B
| $17.1M | 4.42% | 61,327 -45,033 | -42% | -$12.5M |
|
|
9
IDEAYA Biosciences
IDYA
$2.15B
| $16.8M | 4.37% | 531,630 +109,581 | +26% | +$3.47M |
|
|
10
Baxter International
BAX
$12.7B
| $16.8M | 4.35% | 441,821 -279,457 | -39% | -$10.6M |
|
|
BERY
11
DELISTED
Berry Global Group, Inc.
BERY
| $16.7M | 4.32% | 244,982 -14,728 | -6% | -$1M |
|
12
IQVIA
IQV
$32.4B
| $16M | 4.15% | 67,582 -27,152 | -29% | -$6.43M |
|
13
Amphastar Pharmaceuticals
AMPH
$1.42B
| $15.4M | 3.98% | 316,556 -178,533 | -36% | -$8.66M |
|
|
14
Orthofix Medical
OFIX
$592M
| $14.5M | 3.77% | 930,507 +155,139 | +20% | +$2.42M |
|
15
Viking Therapeutics
VKTX
$3.04B
| $12.2M | 3.17% | 192,889 +18,123 | +10% | +$1.15M |
|
|
16
Perrigo
PRGO
$3.27B
| $11.9M | 3.07% | +452,221 | New | +$11.9M |
|
17
Certara
CERT
$1.74B
| $6.34M | 1.64% | 541,830 -177,153 | -25% | -$2.07M |
|
|
18
Charles River Laboratories
CRL
$8.04B
| – | – | -48,288 | Closed | -$9.98M |
|
19
Healthcare Services Group
HCSG
$1.13B
| – | – | -873,018 | Closed | -$9.24M |
|
20
Tarsus Pharmaceuticals
TARS
$2.47B
| – | – | -216,047 | Closed | -$5.87M |
|
|
21
Xenon Pharmaceuticals
XENE
$2.98B
| – | – | -250,460 | Closed | -$9.77M |
|